Elucidating anti-triple-negative breast cancer mechanisms and mitigating toxicity of Fritillaria thunbergii Miq.: A multi-omics and network pharmacology approach.

Fritillaria thunbergii Miq. (Zhebeimu, ZBM) is traditionally recognized in Chinese medicine for its effects of clearing heat, resolving phlegm, suppressing cough, detoxifying, dissipating nodules, and resolving abscesses—properties that align closely with the pathogenesis of breast cancer. Classical...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Ethnopharmacology Vol. 355
Autores principales: Zhu, Yubin, Zhang, Yuqing, Li, Xinni, Zhang, Luyao, Shen, Zhixin
Formato: research Journal Article
Publicado: Elsevier B.V. Jan2026:Part A
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=188929539&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 188929539
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        03788741
        3MS
      jtl: Journal of Ethnopharmacology
      issn: 03788741
      maglogo: N
    pubinfo:
      dt: Jan2026:Part A
      vid: 355
      pid: 1004
      pub: Elsevier B.V.
    artinfo:
      ui:
        188929539
        188929539
        188929539
        10.1016/j.jep.2025.120600
        188929539
      ppct: 1
      formats:
      tig:
        atl: Elucidating anti-triple-negative breast cancer mechanisms and mitigating toxicity of Fritillaria thunbergii Miq.: A multi-omics and network pharmacology approach.
      aug:
        au:
          Zhu, Yubin
          Zhang, Yuqing
          Li, Xinni
          Zhang, Luyao
          Shen, Zhixin
        affil: School of Clinical Medicine, Shandong Second Medical University, 261053, Weifang, China
      sug:
        subj:
          Drugs, Chinese Herbal Therapeutic Use
          Breast Neoplasms Drug Therapy
          Drugs, Chinese Herbal Pharmacodynamics
          Drugs, Chinese Herbal Adverse Effects
          Toxicology
          Drug Efficacy Evaluation
          Human
          Organic Chemicals Analysis
          Multiomics
          Sequence Analysis
          Machine Learning Algorithms
          Autophagy Drug Effects
          Genes Drug Effects
          Molecular Docking Simulation
          Descriptive Statistics
          Network Pharmacology
          Antineoplastic Agents Pharmacodynamics
          Hepatotoxicity
          Nephrotoxicity
          Receptors, Cell Surface Drug Effects
      ab: Fritillaria thunbergii Miq. (Zhebeimu, ZBM) is traditionally recognized in Chinese medicine for its effects of clearing heat, resolving phlegm, suppressing cough, detoxifying, dissipating nodules, and resolving abscesses—properties that align closely with the pathogenesis of breast cancer. Classical texts including Shennong Bencao Jing and Bencao Zheng document its historical use in breast cancer treatment. This study aims to evaluate the potential therapeutic mechanisms and safety profile of the traditional Chinese medicine ZBM against triple-negative breast cancer (TNBC) using in silico methodologies. This computational study integrated network pharmacology, machine learning, and single-cell RNA sequencing to systematically identify ZBM's bioactive components and potential targets against TNBC. Molecular docking and dynamics simulations were employed to characterize interactions between key compounds and targets, while network toxicology assessed potential toxicity risks. Our multi-omics approach identified 42 bioactive ZBM components and 148 potential TNBC targets. Among these, machine learning algorithms prioritized five key autophagy-related genes, with CXCR4 selected as the core autophagy-associated target for computational validation. Molecular simulations predicted strong binding between hapepunine and CXCR4. Meanwhile, subtype analysis at the single-cell level revealed that BL TNBC subtypes may be particularly sensitive to ZBM compounds. Network toxicology revealed potential hepatotoxicity/nephrotoxicity risks. These risks were computationally mitigated through structural optimization of hapepunine derivatives. This study not only provides a novel mechanistic framework for ZBM's anti-TNBC activity but also demonstrates the utility of network toxicology coupled with structural optimization in proactively identifying and mitigating potential toxicity liabilities of natural product derivatives. [Display omitted] • Proposes potential anti-TNBC mechanism of Fritillaria thunbergii Miq., filling a key theoretical gap. • Integrated multi-omics deciphers pharmacology of Fritillaria thunbergii Miq. against TNBC. • Machine learning and scRNA-seq identify CXCR4 as Fritillaria thunbergii Miq's key target activating autophagy in TNBC. • Network toxicology and database mining reveal Fritillaria thunbergii Miq's multi-organ toxicity risks. • Computer-aided drug design-guided structural optimization reduces hapepunine's toxicity while enhancing its affinity for CXCR4.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N